Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism - the J-EINSTEIN DVT and PE program
about
Remarkable regression of massive deep vein thrombosis in response to intensive oral rivaroxaban treatmentShort-Term Anticoagulant Therapy and Thrombus Location Are Independent Risk Factors for Delayed Recanalization of Deep Vein ThrombosisMortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials.Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Japan.The Successful Prevention of Thromboembolism Using Rivaroxaban in a Patient with Antithrombin Deficiency during the Perioperative Period.Novel Anticoagulant Therapy of Venous Thromboembolism: Current Status and Future Directions.Erratum to: 'Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism - the J-EINSTEIN DVT and PE program'.Ambulant treatment for a very elderly patient with acute deep vein thrombosis in a rural area: A case report.The diagnosis and treatment of venous thromboembolism in asian patients.The clinical course of symptomatic deep vein thrombosis after 3 months of anticoagulant therapy using fondaparinux/edoxaban or fondaparinux/vitamin K antagonist.Rivaroxaban Treatment for Warfarin-Refractory Thrombosis in a Patient with Hereditary Protein S Deficiency.Design and rationale for the Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients with Deep Vein Thrombosis and Pulmonary Embolism (J'xactly) study.Pulmonary Embolism: Contemporary Medical Management and Future Perspectives
P2860
Q35191153-99F34230-005F-49D3-A729-CDC00D1519BBQ36504050-58EB48CB-0862-4B94-B3B1-79F76262D227Q38584212-FF49D039-720A-4896-A51A-4CA95314C762Q41769701-E883C868-A4FE-485C-B4F8-A1E0361C5543Q42078764-47B51755-F008-45F9-9D91-72EF3AA1AAE9Q42352700-C2BA71E2-8C2B-47E5-A5B1-93B970BD0215Q42767118-F85C79FF-5969-482E-B2C1-72D7831E65F9Q47100893-0B4FFBCA-6DDB-4738-93CB-2CB30420B0A2Q47644500-450B8E26-FA96-458E-8939-E459E75503EEQ51744592-9642E88D-701F-4052-BF7E-AD79610EBDF8Q55199012-3CE0245E-BB41-4036-BC5A-4A07467457ABQ55371591-F6CCA4CA-E8BD-41D7-B1B9-61455C287AFAQ58551043-E40780C8-FAB8-407B-9BA5-3625F0AAF690
P2860
Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism - the J-EINSTEIN DVT and PE program
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Oral rivaroxaban for Japanese ...... J-EINSTEIN DVT and PE program
@ast
Oral rivaroxaban for Japanese ...... J-EINSTEIN DVT and PE program
@en
type
label
Oral rivaroxaban for Japanese ...... J-EINSTEIN DVT and PE program
@ast
Oral rivaroxaban for Japanese ...... J-EINSTEIN DVT and PE program
@en
prefLabel
Oral rivaroxaban for Japanese ...... J-EINSTEIN DVT and PE program
@ast
Oral rivaroxaban for Japanese ...... J-EINSTEIN DVT and PE program
@en
P2093
P2860
P1433
P1476
Oral rivaroxaban for Japanese ...... J-EINSTEIN DVT and PE program
@en
P2093
Anthonie Wa Lensing
Atsushi Hirayama
Hideaki Maeda
Hiroo Shikata
Junichi Onuma
Kazuma Iekushi
Mariko Kajikawa
Martin H Prins
Masaharu Kato
Norikazu Yamada
P2860
P2888
P356
10.1186/S12959-015-0035-3
P577
2015-01-17T00:00:00Z
P5875
P6179
1013719894